Tech

Technology

There's a way to do it better. - Thomas Edison

Ready-to-Deploy Technology

These technologies are sourced from amazing startups from around the world. Most have IP rights protected, and all would scale much more quickly with investment in hand. These are great opportunities to invest in global health.

24-hour hand sanitizer

Hand sanitizer that protects and shields from microbes for 24 hours

90-day Surface Sanitizer

Surface sanitizer that provides microbe resistance for 90 days . This company is currently fulfilling a contract with a major city to sanitize over 6000 public transit vehicles.

UV-treated Masks

Respiratory mask that incorporates ultraviolet technology to filter and purify incoming and outgoing air

Mass Air Disinfectant

A human-friendly and earth friendly hypochlorous disinfection technology generated from an EPA approved on-site device that can be combined with a fine mist to attack microbes in the air as well as on surfaces in aircraft, hospital rooms, hotel rooms, on cruise ships, food facilities and large conference facilities.

Microbe-Resistant Textiles

A sanitizing product for garments that provides microbe resistance for the life of the garment This product can provide essential immediate protection in hospitals by sanitizing scrubs and caregiver uniforms.

Mask Sanitizing Spray

A spray-on mask sanitizer and air inhalation purifier that raises protection N90, blocking COVID-19 and other viruses.

UV Air Filter

A proprietary ultraviolet light filtering system to remove microbes from the air and from water.

Technology in Development

For these projects we seek grant and investment funding for R&D and to accelerate production and testing of prototypes. Solutions that can be expedited into commercialization and deployment with Government and/or investor support include:

Viruses to Oxygen

Technology that converts toxins, including microbes, chemicals and toxic gases, into breathable oxygenated air 

Upgraded HVAC System

Air purifying ventilation and HVAC systems

Diagnostics

Rapid point of care diagnosis products

Vaccines

Vaccine development and testing

Telemedicine

Telemedicine platforms

Share by: